Profile data is unavailable for this security.
About the company
QINGHAI SPRING MEDICINAL RESOURCES TECHNOLOGY CO.,LTD is a China-based company that principally engaged in the integrated development, utilization, production, sales and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company’s main products are the cordyceps sinensis series products under Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis and raw cordyceps sinensis. The Company’s subsidiary is Qinghai Spring Pharmaceutical Resource Utilization Co Ltd.
- Revenue in CNY (TTM)244.84m
- Net income in CNY-277.14m
- Incorporated1998
- Employees173.00
- LocationQinghai Spring Medicinal Resources Technology Co Ltd16F, Ningjing Business CenterXINING 810000ChinaCHN
- Phone+86 9 718816171
- Fax+86 9 718816171
- Websitehttps://www.verygrass.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shaanxi Kanghui Pharmaceutical Co Ltd | 669.33m | -47.46m | 1.26bn | 952.00 | -- | 1.34 | -- | 1.88 | -0.4752 | -0.4752 | 6.70 | 9.42 | 0.3167 | 1.94 | 3.35 | 703,079.60 | -3.63 | -0.1562 | -5.54 | -0.1991 | 26.27 | 40.00 | -11.48 | -0.4907 | 0.8792 | -0.7684 | 0.4201 | 95.15 | 36.92 | 12.37 | 58.52 | -- | 66.95 | -- |
Qinghai Spring Medicinl Rsrcs Tech CoLTD | 244.84m | -277.14m | 1.53bn | 173.00 | -- | 1.28 | -- | 6.23 | -0.4721 | -0.4721 | 0.417 | 2.03 | 0.1757 | 0.4712 | 4.67 | 1,415,236.00 | -19.74 | -11.25 | -20.38 | -11.55 | 48.62 | 23.44 | -112.37 | -129.81 | 8.87 | -0.8971 | 0.0135 | -- | 33.52 | -8.48 | 6.85 | -- | -20.83 | -- |
Jiangsu gdk Biotechnology Co Ltd | 10.74m | -146.94m | 1.53bn | 451.00 | -- | 1.15 | -- | 142.28 | -1.19 | -1.19 | 0.0871 | 10.80 | 0.0064 | 0.1697 | 0.0778 | 23,806.61 | -8.73 | 3.30 | -10.20 | 4.84 | -1.88 | 75.56 | -1,368.55 | 12.58 | 3.10 | -- | 0.0412 | 32.60 | -57.74 | -- | -270.88 | -- | 54.07 | -- |
Shanghai Shen Lian Biomedical Corp | 304.79m | -12.92m | 1.91bn | 380.00 | -- | 1.32 | -- | 6.25 | -0.0315 | -0.0315 | 0.7422 | 3.51 | 0.196 | 0.9229 | 1.15 | 802,082.80 | -1.06 | 5.39 | -1.12 | 5.84 | 64.36 | 77.45 | -5.42 | 25.48 | 5.16 | -- | 0.0015 | 38.49 | -8.25 | 1.85 | -48.41 | -18.49 | 10.47 | -- |
Shanghai Serum Bio-Technology Co Ltd | 194.44m | 44.17m | 2.06bn | 321.00 | 46.57 | 1.88 | -- | 10.58 | 0.4082 | 0.4082 | 1.80 | 10.13 | 0.1738 | 1.03 | 3.49 | 605,741.10 | 3.95 | 10.43 | 4.02 | 10.84 | 75.64 | 80.54 | 22.72 | 32.57 | 49.77 | -- | 0.0114 | 64.93 | 9.14 | 5.67 | -39.54 | -1.62 | 13.07 | -- |
Data as of Oct 11 2024. Currency figures normalised to Qinghai Spring Medicinal Resources Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Gfund Management Co., Ltd.as of 31 Dec 2023 | 768.40k | 0.13% |
Hongde Fund Management Co., Ltd.as of 31 Dec 2023 | 251.20k | 0.04% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 172.80k | 0.03% |
HFT Investment Management Co., Ltd.as of 31 Dec 2023 | 49.10k | 0.01% |
The Vanguard Group, Inc.as of 30 Jun 2024 | 2.30k | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.